Haemophilus Influenzae B Vaccine clinical trials
How each study uses Haemophilus Influenzae B Vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
PT Bio Farma (3) · LG Life Sciences (2) · Sanofi Pasteur, a Sanofi Company (1) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1) · GlaxoSmithKline (1)
Often tested with
Tested in the same studies.
13-valent pneumococcal vaccine (1) · RotaTeq (1) · Hepatitis B Vaccines (1) · Chickenpox Vaccine (1)
Studies
Open first, then newest update. How each study uses Haemophilus Influenzae B Vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT03691610Written as Haemophilus b Conjugate VaccineHow we know
- Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years OldCompletedPhase 2Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdNCT04865497Written as Haemophilus b Conjugate VaccineHow we know
- Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.TerminatedPhase 3GlaxoSmithKlineNCT00316680Written as Diphtheria, tetanus, pertussis, hepatitis B, Hib vaccineHow we know
- Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center TrialCompletedPhase 3PT Bio FarmaNCT01986335Written as DTP/HB/Hib VaccineHow we know
- Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)VaccineCompletedPhase 2PT Bio FarmaNCT01986322Written as DTP/HB/Hib vaccineHow we know
- The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)CompletedPhase 1PT Bio FarmaNCT01977196Written as DPT/HepatitisB/Hib vaccineHow we know
- Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 StudyCompletedPhase 3LG Life SciencesNCT01251133Written as LBVH0101 (Hib vaccine)How we know
- Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of AgeCompletedPhase 3LG Life SciencesNCT01019772Written as LBVH0101 (Hib vaccine)How we know
Given beside what is tested · 3 — Haemophilus Influenzae B Vaccine is usual care or a partner of the new treatment
- Baby Vaccine Study (Sched3)CompletedPhase 2University of OxfordNCT02482636Written as DTaP/IPV/Hib vaccineHow we know
- Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)CompletedPhase 3GlaxoSmithKlineNCT01345240Written as Infanrix/Hib™ vaccineHow we know
- Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsCompletedPhase 3NovartisNCT00806195Written as Hib (Haemophilus influenza b) VaccineHow we know
As the comparator · 5 — what is tested is compared with Haemophilus Influenzae B Vaccine
- Confirmatory Study of BK1310 in Healthy InfantsCompletedPhase 3Tanabe Pharma CorporationNCT03891758Written as Hib vaccineHow we know
- Phase 3 Study of BK1310 in Healthy InfantsCompletedPhase 3Tanabe Pharma CorporationNCT02992925Written as Hib vaccineHow we know
- PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus PneumoniaeCompletedNot applicableCenters for Disease Control and Prevention, ChinaNCT02133469Written as Hib VaccineHow we know
- Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate VaccineCompletedPhase 3Jiangsu Province Centers for Disease Control and PreventionNCT01580033Written as Hib vaccineHow we know
- Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and ChildrenCompletedPhase 3Jiangsu Province Centers for Disease Control and PreventionNCT01428908Written as Hib vaccineHow we know